BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $348,000 | +47.5% | 17,500 | -4.0% | 0.02% | +16.7% |
| Q2 2016 | $236,000 | -16.0% | 18,225 | -39.2% | 0.02% | +50.0% |
| Q1 2016 | $281,000 | -45.6% | 30,000 | +17.6% | 0.01% | -66.7% |
| Q4 2015 | $517,000 | +73.5% | 25,500 | +24.4% | 0.04% | +176.9% |
| Q3 2015 | $298,000 | -74.3% | 20,500 | -59.0% | 0.01% | -74.5% |
| Q1 2015 | $1,159,000 | +0.6% | 50,000 | 0.0% | 0.05% | +27.5% |
| Q4 2014 | $1,152,000 | – | 50,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 1,026,402 | $21,832,000 | 2.20% |
| Avoro Capital Advisors LLC | 262,515 | $5,584,000 | 1.54% |
| Lamond Capital Partners LLC | 68,780 | $1,463,000 | 1.48% |
| Green Owl Capital Management, LLC | 90,000 | $1,914,000 | 1.36% |
| Baker Brothers Advisors | 4,190,594 | $89,134,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,514 | $4,924,000 | 0.48% |
| Redmile Group, LLC | 238,121 | $5,065,000 | 0.42% |
| Highlander Capital Management, LLC | 19,250 | $409,000 | 0.37% |
| Spark Investment Management LLC | 110,500 | $2,350,000 | 0.33% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 145,380 | $3,092,000 | 0.24% |